ProPhase Labs to Host First Quarter 2022 Financial Results Conference Call on Friday, May 13, 2022 at 11:00 a.m. Eastern Time
06 mai 2022 16h30 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, May 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, will hold a conference call on Friday, May 13, 2022 at 11:00...
ProPhase Labs to Present at the Planet MicroCap Showcase 2022 on Wednesday, May 4, 2022
27 avr. 2022 08h15 HE
|
ProPhase Labs, Inc.
Garden City, NY, April 27, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present...
ProPhase Labs Announces Record Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021
30 mars 2022 08h30 HE
|
ProPhase Labs, Inc.
Record Financial Results also expected for Q1 2022 Company to hold a conference call March 30, 2022, at 11:00AM ET Garden City, NY, March 30, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs,...
ProPhase Labs to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Wednesday, March 30, 2022 at 11:00 a.m. Eastern Time
24 mars 2022 08h15 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, March 24, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified company offering a range of services including diagnostic testing, genomics testing and contract...
ProPhase Labs Announces Special Cash Dividend
16 févr. 2022 08h15 HE
|
ProPhase Labs, Inc.
Anticipates Record Q4 2021 and Q1 2022 Revenues and Profits Garden City, NY, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company,...
ProPhase Labs to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Conference
03 févr. 2022 08h30 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Feb. 03, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
ProPhase Labs Announces Record COVID-19 Testing in Q4 2021
13 janv. 2022 08h15 HE
|
ProPhase Labs, Inc.
Q1 2022 Testing Volumes will Significantly Exceed Previous Record Results from Q1 2021 Significant year-over-year growth expected for the next four quarters Garden City, NY, Jan. 13, 2022 (GLOBE...
ProPhase Labs to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference
05 janv. 2022 08h30 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 05, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present a...
ProPhase Labs Continues to Build Strong Leadership with Key Promotions and Additions to Management Team
16 déc. 2021 08h30 HE
|
ProPhase Labs, Inc.
Precision Medicine division adds Industry Veteran Sam A. Beeler as Chief Strategy Officer; Diagnostics Division Promotes Alice Lioi and Jason Karkus to EVP and Co-Chief Operating Officers and Sergio...
PROPHASE LABS, INC. ANNOUNCES INDUCEMENT AWARD UNDER NASDAQ LISTING RULE 5635(C)(4)
23 nov. 2021 16h15 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 23, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that it has granted an inducement award to a new...